1. 2022-RA-1392-ESGO Tisotumab vedotin combinations with pembrolizumab or carboplatin in patients with recurrent/metastatic cervical cancer: interim results of ENGOT Cx8/GOG-3024/innovaTV205. (20th October 2022) Authors: Lorusso, Domenica; Vergote, Ignace; O'Cearbhaill, Roisin E; Westermann, Anne M; Banerjee, Susana; van Nieuwenhuysen, Els; Iglesias, David A; Collins, Dearbhaile; Cibula, David; Madsen, Kristine; Tewari, Krishnansu S; Pignata, Sandro; Baurain, Jean-Francois; Boere, Ingrid A; Denys, Hannelore; Andr... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1548-ESGO Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer. (20th October 2022) Authors: Vergote, Ignace; Mirza, Mansoor; Sehouli, Jalid; Lorusso, Domenico; Kose, Fatih; Cibula, David; Westermann, Anneke; Collins, Dearbhaile; Banerjee, Susana; Oaknin, Ana; Soumaoro, Ibrahima; Jain, Shweta; Monk, Bradley J Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 617 Tisotumab vedotin shows immunomodulatory activity through induction of immunogenic cell death. (9th November 2020) Authors: Gray, Elizabeth; Hensley, Kelly; Allred, Sean; Trueblood, Esther; Gosink, John; Thurman, Robert; Smith, Kaleb; Jacquemont, Celine; Bieda, Mark; Gow, Jason; Harris, Jeffrey; Brady, Lauren; Soumaoro, Ibrahima; Jain, Shweta; Nicacio, Leonardo; Gardai, Shyra Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EP064/#192 Potential mechanism for ocular adverse events observed with tisotumab vedotin. (4th December 2022) Authors: Vergote, Ignace; Kim, Stella; Ursell, Paul; Pignata, Sandro; Gonzalez-Martin, Antonio; Randall, Leslie; Melichar, Bohuslav; Madsen, Kristine; Mahner, Sven; Lorusso, Domenica; Henry, Stéphanie; Gaba, Lydia; Salcedo, Theodora; Neff-Laford, Haley; Harris, Jeffrey; Jiang, Joy; Soumaoro, Ibrahima; Jai... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study. Issue 8 (15th June 2022) Authors: Yonemori, Kan; Kuboki, Yasutoshi; Hasegawa, Kosei; Iwata, Takashi; Kato, Hidenori; Takehara, Kazuhiro; Hirashima, Yasuyuki; Kato, Hisamori; Passey, Chaitali; Buchbjerg, Jeppe Klint; Harris, Jeffrey R.; Andreassen, Camilla Mondrup; Nicacio, Leonardo; Soumaoro, Ibrahima; Fujiwara, Keiichi Journal: Cancer science Issue: Volume 113:Issue 8(2022) Page Start: 2788 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. TP004/#1457 Trial in progress of engot-CX8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer. (4th December 2022) Authors: Vergote, Ignace; Mirza, Mansoor; Sehouli, Jalid; Lorusso, Domenica; Köse, Fatih; Cibula, David; Westermann, Anneke; Collins, Dearbhaile; Banerjee, Susana; Oaknin, Ana; Soumaoro, Ibrahima; Jain, Shweta; Monk, Bradley Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗